A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

The MC4R agonist targets rare genetic and hypothalamic obesity, with potential as a combination or maintenance therapy for general obesity alongside GLP-1 agents.

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

A research team led by the Leibniz-HKI in Jena has uncovered a new way in which the yeast Candida albicans can damage human ...

The sculpture represents a collagen molecule, the most abundant protein in the human body, and serves as “an allusion to the ...

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

Taarika Dave, holistic life coach and yoga expert at the Luke Coutinho Holistic Healing Systems, explains how you can improve ...

Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.

STRUGGLING to get a decent night’s sleep? Well, you aren’t alone, Brits are one of the world’s most sleep deprived countries ...

Princeton, New Jersey Tuesday, July 22, 2025, 12:00 Hrs [IST] ...

Shares of Pidilite Industries Ltd., Heritage Foods Ltd., Aditya Birla Sun Life AMC and 13 other companies will be of interest ...